|
Market Closed -
Sao Paulo
15:43:07 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 9.230 BRL | +4.41% |
|
+25.92% | -55.84% |
| 10-19 | Ultragenyx Pharmaceutical Enters Settlement With Navinta Over Dojolvi | MT |
| 10-14 | Ultragenyx Pharmaceutical to Sell Priority Review Voucher for $203 Million | DJ |
Chart: Technical Analysis
Sao PauloBRL
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RARE | Delayed | |
CBOE
| RARE | Real-time | |
|
Tradegate
| UP0 | Real-time | |
|
Berne S.E.
| UP0 | End-of-day quote | |
|
Boerse Muenchen
| UP0 | Real-time | |
|
Mexican S.E.
| RARE * | End-of-day quote | |
|
Xetra
| UP0 | Delayed | |
|
Deutsche Boerse AG
| UP0 | Delayed | |
|
Börse Stuttgart
| UP0 | Delayed | |
Sao Paulo
| R2AR34 | Delayed |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RARE Stock
- R2AR34 Stock
- Charts Ultragenyx Pharmaceutical Inc.
Select your edition
All financial news and data tailored to specific country editions
